| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥8.14B | +45.1% |
| Gross profit | ¥2.29B | — |
| Operating income | ¥1.53B | — |
| Net income | ¥1.33B | +109.9% |
| Gross margin | 28.1% | Net margin 16.4% |
| Revenue Q/Q | +4.1% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥5.85B | 71.9% |
| R&D | ¥0.40B | 4.9% |
| SG&A | ¥0.41B | 5.0% |
| Tax & other | ¥0.20B | 2.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
兖矿能源 ・ 复星医药 ・ 南山铝业 ・ 海航控股 ・ 圆通速递 ・ 恒瑞医药 ・ 万华化学 ・ 恒力石化 ・ 江西铜业 ・ 中航机载 ・ 国电南瑞 ・ 小商品城
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies